GLSI Next Earnings Date Notes

— Greenwich LifeSciences (ticker: GLSI) is a clinical-stage biopharmaceutical company focused on discovering & developing immunotherapies to prevent the recurrence of breast cancer, most notably through its lead product candidate, GP2. GP2 is a peptide-based immunotherapy targeting HER2-positive breast cancer patients who have completed standard treatments, aiming to reduce recurrence risk & improve long-term survival. As an investor listening to the GLSI earnings call, consider tracking key business metrics such as the enrollment & progress of clinical trial phases (especially the pivotal Phase III Flamingo-01 trial), trial data readouts demonstrating efficacy & safety, cash burn rate, and projected runway based on cash and equivalents. Milestones related to regulatory interactions or approvals (e.g., IND filings, SPA agreements, or FDA feedback) are also critical, as they shape the path to commercialization. Additionally, potential partnership developments, licensing agreements, or strategic collaborations can impact long-term value. Since GLSI does not yet generate product revenue, pipeline advancement & financial sustainability are the most relevant indicators of future success. The next projected earnings date for GLSI is 11/13/2026 after close (stay tuned for a confirmed earnings date once announced).

GLSI Next Earnings Date FAQ

On this page we presented the GLSI Next Earnings Date information for Greenwich LifeSciences along with recent past earnings dates. For Q2 of 2026, GLSI reported earnings of -0.270/share, with the earnings report taking place on 8/11/2026. For Q1 of 2026, GLSI reported earnings of /share, with the earnings report taking place on 7/17/2026. For Q1 of 2026, GLSI reported earnings of -0.390/share, with the earnings report taking place on 6/3/2026. For Q3 of 2025, GLSI reported earnings of /share, with the earnings report taking place on 12/2/2025. For Q3 of 2025, GLSI reported earnings of -0.300/share, with the earnings report taking place on 11/14/2025. Based on these past earnings dates, the projected next earnings date for GLSI is 11/13/2026 after market close.

Any self directed investor who desires to keep tabs on the companies they own, can benefit from maintaining a calendar of next earnings dates for each stock in their porfolio, such as Greenwich LifeSciences. When a company files its 10Q's with the SEC a mere four times a year, that certainly puts a lot of pressure on those four out of three hundred sixty five days! To say that earnings reports are important to Greenwich LifeSciences shareholders would thus be an understatement! That's why we started the NextEarningsDate.com website, to make it easy for self directed investors to research Greenwich LifeSciences next earnings dates as well as any other stock out there in our coverage universe, to see when the next GLSI earnings date — or any other stock — falls on the calendar. But we also present considerably more than just the next earnings date information alone, so we encourage you to explore the additional pages linked above to look up GLSI's past earnings as well, with pages for revenue and earnings history data, as well as earnings surprises as well. Thanks for visiting, and we hope you'll think of our site the next time you need to learn about the GLSI next earnings date.